CRCGN015_MCF10A.WT.HP_24H:N14 Gene Set
Genes
26 genes differentially expressed following the CRCGN015_MCF10A.WT.HP_24H:N14 small molecule perturbation from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
4.00576
|
|
ADO
|
2-aminoethanethiol (cysteamine) dioxygenase
|
3.59318
|
|
E2F2
|
E2F transcription factor 2
|
3.46271
|
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
3.33872
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
2.9199
|
|
TBPL1
|
TBP-like 1
|
2.77132
|
|
EDEM1
|
ER degradation enhancer, mannosidase alpha-like 1
|
2.74608
|
|
PEX11A
|
peroxisomal biogenesis factor 11 alpha
|
2.64141
|
|
SV2B
|
synaptic vesicle glycoprotein 2B
|
2.33762
|
|
CCNA1
|
cyclin A1
|
2.33229
|
|
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
|
2.17235
|
|
GNA15
|
guanine nucleotide binding protein (G protein), alpha 15 (Gq class)
|
2.12973
|
|
STMN2
|
stathmin 2
|
2.12157
|
|
NSG2
|
neuronal vesicle trafficking associated 2
|
2.10407
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
2.04919
|
|
NRBF2
|
nuclear receptor binding factor 2
|
2.03483
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
2.02924
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
NPDC1
|
neural proliferation, differentiation and control, 1
|
-6.43912
|
|
TES
|
testin LIM domain protein
|
-3.93731
|
|
DNAJA3
|
DnaJ (Hsp40) homolog, subfamily A, member 3
|
-2.99934
|
|
DSG2
|
desmoglein 2
|
-2.75208
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
-2.66162
|
|
MSMO1
|
methylsterol monooxygenase 1
|
-2.5971
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
-2.51578
|
|
MEST
|
mesoderm specific transcript
|
-2.1233
|
|
FBXO21
|
F-box protein 21
|
-2.0303
|
